ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks Education
Visit Zacks' Education section for investing guides and other free resources to make you a better investor.

Quote:

Search for Ticker

Free Membership

Search:

PLX: Protalix Biotherapeutics Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

PROTALIX BIOTHERAPEUTICS INC (AMEX)
PLX	7.04	-0.06	(-0.85%)	Vol. 109,740	10:33 ET

ORTHODONTIX INC. is engaged in the provision of practice management services to the Affiliated Practices pursuant to long-term Administrative Services Agreements with separately organized affiliated professional associations. Under the Administrative Services Agreements, they have control over all non-orthodontic functions of the PA Contractors, including administrative, management, billing and support functions.

General Information

PROTALIX BIOTHR

2 Sunnit Street Science Park Carmiel, - 20100 Phone: 972 4 988 9488 Fax: 972 4 988 9489 Web: www.protalix.com Email: mstrickler@troutgroup.com

Industry	MED-BIOMED/GENE
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	12/31/09
Next EPS Date	02/10/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	7.10
52 Week High	12.50
52 Week Low	1.99
Beta	1.60
20 Day Moving Average	556,387.94
Target Price Consensus	12

% Price Change
4 Week	-4.83
12 Week	-31.27
YTD	7.25

% Price Change Relative to S&P 500
4 Week	1.02
12 Week	-28.71
YTD	7.59

Share Information
Shares Outstanding (millions)	77.27
Market Capitalization (millions)	548.59
Short Ratio	9.55
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.18
Current Year EPS Consensus Estimate	-0.02
Estimated Long-Term EPS Growth Rate	-
Next EPS Report Date	02/10/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.00
30 Days Ago	1.00
60 Days Ago	1.00
90 Days Ago	1.00

Fundamental Ratios

P/E
Current FY Estimate:	-
Trailing 12 Months:	-
PEG Ratio	-

EPS Growth
vs. Previous Year	-%
vs. Previous Quarter	-%

Sales Growth
vs. Previous Year	-%
vs. Previous Quarter:	-%

Price Ratios
Price/Book	18.09
Price/Cash Flow	-
Price / Sales	-

ROE
12/31/09	-
09/30/09	-104.42
06/30/09	-68.20

ROA
12/31/09	-
09/30/09	-87.70
06/30/09	-59.20

Current Ratio
12/31/09	-
09/30/09	3.67
06/30/09	5.00

Quick Ratio
12/31/09	-
09/30/09	3.67
06/30/09	5.00

Operating Margin
12/31/09	-
09/30/09	-
06/30/09	-

Net Margin
12/31/09	-
09/30/09	-
06/30/09	-

Pre-Tax Margin
12/31/09	-
09/30/09	-
06/30/09	-

Book Value
12/31/09	-
09/30/09	0.39
06/30/09	0.46

Inventory Turnover
12/31/09	-
09/30/09	-
06/30/09	-

Debt-to-Equity
12/31/09	-
09/30/09	0.00
06/30/09	0.00

Debt to Capital
12/31/09	-
09/30/09	0.00
06/30/09	0.00


About Zacks \| Advertise \| Affiliate \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2010 Zacks Investment Research